Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis
Min Seo Kim, Min Ho An, Won Jun Kim, et al.
PLoS Medicine (2020) Vol. 17, Iss. 12, pp. e1003501-e1003501
Open Access | Times Cited: 203

Showing 1-25 of 203 citing articles:

Association between adiposity and cardiovascular outcomes: an umbrella review and meta-analysis of observational and Mendelian randomization studies
Min Seo Kim, Won Jun Kim, Amit V. Khera, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3388-3403
Open Access | Times Cited: 212
Effect of Early Treatment with Ivermectin among Patients with Covid-19
Gilmar Reis, Eduardo A.S.M. Silva, Daniela C.M. Silva, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 18, pp. 1721-1731
Open Access | Times Cited: 201
Self-medication practices to prevent or manage COVID-19: A systematic review
Alvaro Quincho-Lopez, Christeam A. Benites-Ibarra, Maryori M. Hilario-Gómez, et al.
PLoS ONE (2021) Vol. 16, Iss. 11, pp. e0259317-e0259317
Open Access | Times Cited: 95
Misleading clinical evidence and systematic reviews on ivermectin for COVID-19
Luis Garegnani, Eva Madrid, Nicolás Meza
BMJ evidence-based medicine (2021) Vol. 27, Iss. 3, pp. 156-158
Closed Access | Times Cited: 78
Mediterranean diet and the risk of COVID-19 in the ‘Seguimiento Universidad de Navarra’ cohort
Rafael Pérez-Araluce, Miguel Ángel Martínez‐González, César I. Fernández-Lázaro, et al.
Clinical Nutrition (2021) Vol. 41, Iss. 12, pp. 3061-3068
Open Access | Times Cited: 70
Lactoferrin as Antiviral Treatment in COVID-19 Management: Preliminary Evidence
Elena Campione, Caterina Lanna, Terenzio Cosio, et al.
International Journal of Environmental Research and Public Health (2021) Vol. 18, Iss. 20, pp. 10985-10985
Open Access | Times Cited: 61
Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality
Arturo Casadevall, Quigly Dragotakes, Patrick W. Johnson, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 59
Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials
Cathrine Axfors, Perrine Janiaud, Andreas M. Schmitt, et al.
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 59
Vitamin D regulation of the immune system and its implications for COVID-19: A mini review
Linda Bui, Zahra Zhu, Stephanie Hawkins, et al.
SAGE Open Medicine (2021) Vol. 9
Open Access | Times Cited: 56
Effectiveness of corticosteroids to treat severe COVID-19: A systematic review and meta-analysis of prospective studies
Han Li, Bingdi Yan, Rong Gao, et al.
International Immunopharmacology (2021) Vol. 100, pp. 108121-108121
Open Access | Times Cited: 56
Comparative effectiveness of N95, surgical or medical, and non‐medical facemasks in protection against respiratory virus infection: A systematic review and network meta‐analysis
Min Seo Kim, Dawon Seong, Han Li, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 49
Adverse effects of remdesivir, hydroxychloroquine and lopinavir/ritonavir when used for COVID-19: systematic review and meta-analysis of randomised trials
Ariel Izcovich, Reed Siemieniuk, Jessica Bartoszko, et al.
BMJ Open (2022) Vol. 12, Iss. 3, pp. e048502-e048502
Open Access | Times Cited: 46
Interleukin-1 blocking agents for treating COVID-19
Mauricia Davidson, Sonia Menon, Anna Chaimani, et al.
Cochrane library (2022) Vol. 2022, Iss. 1
Open Access | Times Cited: 38
The scenario of self-medication practices during the covid-19 pandemic; a systematic review
Abhigan Babu Shrestha, Manjil Aryal, Junu Rana Magar, et al.
Annals of Medicine and Surgery (2022) Vol. 82
Open Access | Times Cited: 38
Anakinra for the treatment of COVID-19 patients: a systematic review and meta-analysis
Karolina Dahms, Agata Mikołajewska, Kelly Ansems, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 26
Is antiviral treatment at the acute phase of COVID-19 effective for decreasing the risk of long-COVID? A systematic review
César Fernández‐de‐las‐Peñas, Juan Torres‐Macho, Jesus Alfonso Catahay, et al.
Infection (2023) Vol. 52, Iss. 1, pp. 43-58
Closed Access | Times Cited: 23
Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a Systematic review and meta-analysis
Fotios Barkas, Sempastian Filippas-Ntekouan, Maria Kosmidou, et al.
Lara D. Veeken (2021) Vol. 60, Iss. 12, pp. 5527-5537
Open Access | Times Cited: 44
Consumption Trends of Antibiotics in Brazil During the COVID-19 Pandemic
Fernando de Sá Del Fiol, Cristiane de Cássia Bergamaschi, Isaltino Pereira De Andrade, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 33
Long COVID: systemic inflammation and obesity as therapeutic targets
Lidiane Lima Florêncio, César Fernández‐de‐las‐Peñas
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 8, pp. 726-727
Open Access | Times Cited: 30
On the Origin of Neutrophil Extracellular Traps in COVID-19
Michal Pastorek, M Dúbrava, Peter Celec
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 28
Clinical efficacy and safety of interferon (Type I and Type III) therapy in patients with COVID-19: A systematic review and meta-analysis of randomized controlled trials
Seungeun Ryoo, Dae-Hyup Koh, Su‐Yeon Yu, et al.
PLoS ONE (2023) Vol. 18, Iss. 3, pp. e0272826-e0272826
Open Access | Times Cited: 15
Comparative efficacy and safety of 20 intravenous pharmaceutical intervention for prevention of etomidate-induced myoclonus: a systematic review and Bayesian network meta-analysis
Lu Chen, Pengxiang Zhou, Zhengqian Li, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
National trends in Azithromycin consumption during 2017–2023 in Kazakhstan: impact of the COVID-19 pandemic and the imperative for enhanced clinical guidelines
Laura Kassym, Assiya Kussainova, Д. В. Семенов, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Effectiveness of pharmacological treatments for COVID-19 due to SARS-CoV-2: a systematic literature review
Carolina García‐Vidal, Júlia de Oliveira Gonzalez, Carlos Lumbreras, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Efficacy of COVID-19 Treatments: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
Chenyang Zhang, Huaqing Jin, Yi Feng Wen, et al.
Frontiers in Public Health (2021) Vol. 9
Open Access | Times Cited: 38
Page 1 - Next Page

Scroll to top